102 related articles for article (PubMed ID: 32082520)
1. Assessment of Immuno-Histochemical Expression of MBD1 in Colorectal Adenocarcinoma and Its Correlations with Prognostic Factors.
Ghaedamini S; Nikbakht M; Soleimani M
Middle East J Dig Dis; 2020 Jan; 12(1):39-44. PubMed ID: 32082520
[TBL] [Abstract][Full Text] [Related]
2. RET Protein Expression in Colorectal Cancer; An Immunohistochemical Assessment.
Ashkboos M; Nikbakht M; Zarinfard G; Soleimani M
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1019-1023. PubMed ID: 33906292
[TBL] [Abstract][Full Text] [Related]
3. Screening of Tumor Suppressor Genes in Metastatic Colorectal Cancer.
Qi L; Ding Y
Biomed Res Int; 2017; 2017():2769140. PubMed ID: 28473981
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease.
Ye S; Yu C; Zhang G; Shi F; Chen Y; Yang J; Wu W; Zhou Y
Oncol Lett; 2020 Sep; 20(3):2411-2419. PubMed ID: 32782558
[TBL] [Abstract][Full Text] [Related]
5. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
[TBL] [Abstract][Full Text] [Related]
6. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
[TBL] [Abstract][Full Text] [Related]
7. Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer Patients.
Pagano C; Navarra G; Gazzerro P; Vitale M; Notarnicola M; Caruso MG; Cavalcanti E; Armentano R; Laezza C; Bifulco M
Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34069924
[TBL] [Abstract][Full Text] [Related]
8. Expression of P33(ING1b) Protein in Colorectal Cancer.
Fallahnezhad S; Nikbakht M; Shokri S
Middle East J Dig Dis; 2016 Jan; 8(1):44-50. PubMed ID: 26933481
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
Kano H; Takayama T; Midorikawa Y; Nagase H
Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
[TBL] [Abstract][Full Text] [Related]
10. Downregulated SIRT6 and upregulated NMNAT2 are associated with the presence, depth and stage of colorectal cancer.
Qi J; Cui C; Deng Q; Wang L; Chen R; Zhai D; Xie L; Yu J
Oncol Lett; 2018 Nov; 16(5):5829-5837. PubMed ID: 30333863
[TBL] [Abstract][Full Text] [Related]
11. An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).
Li L; Chen BF; Chan WY
Int J Mol Sci; 2015 Mar; 16(3):5125-40. PubMed ID: 25751725
[TBL] [Abstract][Full Text] [Related]
12. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
13. MMP13 is a potential prognostic marker for colorectal cancer.
Huang MY; Chang HJ; Chung FY; Yang MJ; Yang YH; Wang JY; Lin SR
Oncol Rep; 2010 Nov; 24(5):1241-7. PubMed ID: 20878116
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kang GH
J Pathol Transl Med; 2018 Sep; 52(5):298-306. PubMed ID: 30016858
[TBL] [Abstract][Full Text] [Related]
18. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
Front Oncol; 2019; 9():394. PubMed ID: 31165042
[TBL] [Abstract][Full Text] [Related]
19. MBD1 and MeCP2 expression in embryos and placentas from transgenic cloned goats.
Jia R; Zhang G; Fan Y; Zhou Z; Wan Y; Zhang Y; Wang Z; Wang F
Zygote; 2017 Aug; 25(4):462-471. PubMed ID: 28669357
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
